Waverley Pharma Inc. (TSXV:WAVE)
Canada · Delayed Price · Currency is CAD 0.0200
0.00 (0.00%)
Nov 2, 2026, 2:14 PM EST
Waverley Pharma Market Cap
Waverley Pharma has a market cap or net worth of CAD 1.08 million as of November 9, 2026. It is the 49,847th most valuable company in the world and the 2,464th biggest in Canada.
Market Cap
1.08M
Enterprise Value
4.64M
Revenue
1.17M
Global Rank
Country Rank
#2,464 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since October 27, 2017, Waverley Pharma's market cap has decreased from 27.00M to 1.08M, a decrease of -96.00%. That is a compound annual growth rate of -30.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 540.00K | -50.00% |
| Dec 22, 2025 | 1.08M | 100.00% |
| Dec 31, 2024 | 540.00K | -60.00% |
| Dec 22, 2023 | 1.35M | -16.67% |
| Dec 28, 2022 | 1.62M | -62.50% |
| Dec 30, 2021 | 4.32M | -36.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 27, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quest PharmaTech | 4.23M |
| Innovotech | 3.27M |
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 1.59M |
| Universal Ibogaine | 1.56M |
| Doseology Sciences | 801.16K |
| MindBio Therapeutics | 655.48K |
| Vaxil Bio | 438.24K |